SYN - Synthetic Biologics Inc. (SYN) CEO Steven Shallcross on Q3 2020 Results - Earnings Call Transcript
Synthetic Biologics, Inc. (SYN) Q3 2020 Earnings Conference Call November 10, 2020 04:30 PM ET Company Participants Vincent Perrone - Director, Corporate Communication Steven Shallcross - Chief Executive Officer & Financial Officer Michael Kaleko - Senior Vice President, Research & Development Vince Wacher - Head-Product & Corporate Development Conference Call Participants Michael Okunewitch - Maxim Group Presentation Operator Good afternoon, and welcome to the Synthetic Biologics' 2020 Third Quarter Investor Conference Call. All participants will be in a listen-only mode. [Operator Instructions] After today’s presentation, there will be an opportunity to ask questions. [Operator Instructions] Please note this event is being recorded. At this time, I would like to turn the call over to Vincent Perrone, Director, Corporate Communication at Synthetic Biologics. Vincent? Vincent Perrone Thanks, Grant and good afternoon, everyone. Welcome to Synthetic Biologics 2020 third quarter investor conference call. Today, I'm joined remotely by Steven Shallcross, Chief Executive
For further details see:
Synthetic Biologics, Inc. (SYN) CEO Steven Shallcross on Q3 2020 Results - Earnings Call Transcript